Companies / Switzerland
Novartis Divests Gerber
April 2007 | Company Finance AlertSwiss drugmaker Novartis has agreed to sell its baby food unit Gerber for US$5.5bn to local food giant Nestlé as, in line with the current trend among multinational pharmaceutical companies, it seeks greater focus on its core operations.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
